Allianz Asset Management
LFCR icon

Allianz Asset Management’s Lifecore Biomedical LFCR Stock Holding History

Allianz Asset Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-32,029
Closed -$357K – 1982
2014
Q1 		$357K Sell
32,029
-1,112
-3% -$12.2K ﹤0.01% 1657
2013
Q4 		$402K Sell
33,141
-348,045
-91% -$4.16M ﹤0.01% 1585
2013
Q3 		$4.65M Buy
381,186
+50,571
+15% +$706K 0.01% 939
2013
Q2 		$4.37M Buy
+330,615
New +$4.57M 0.01% 934

Other funds holding LFCR

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allianz Asset Management's LFCR Position: Q2 2014 in Review

Allianz Asset Management sold out of Lifecore Biomedical (LFCR) in Q2 2014, closing a stake of 32,029 shares — an estimated $357K sold.

Allianz Asset Management first reported a position in LFCR in Q2 2013 and held it in 4 quarters. The position peaked at $4.65M in Q3 2013. 101 funds tracked by Wall St. Rank hold LFCR as of Q2 2014.

  • Allianz Asset Management reported no remaining Lifecore Biomedical position as of Q2 2014 after selling out during the quarter.
  • Allianz Asset Management sold 32,029 Lifecore Biomedical shares in Q2 2014, an estimated $357K.
  • Allianz Asset Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 4 quarters.
  • Allianz Asset Management's Lifecore Biomedical position peaked at $4.65M in Q3 2013.
  • 101 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2014.

Based on Allianz Asset Management's 13F filing for Q2 2014, filed 13 Aug 2014.